Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia
This report provides summarised updates on adverse events following immunisation (AEFIs) of COVID-19 Vaccines in Malaysia.
To receive the latest issues of summary report, you may join the NPRA Safety Information Mailing List by filling out the subscription form at https://forms.gle/x7eim2Z99HKVNSsz6.
Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia (Data as of 11th March 2022)
Introduction
- How NPRA collects adverse event reports?
- How NPRA processes AEFI reports and monitors safety of COVID-19 vaccines?
Total Doses of COVID-19 Vaccines Administered
Rate of Reported Adverse Events
- AEFI responses received via MySejahtera application
- AEFI reports received via NPRA Reporting System
- Booster doses (PICK-B)
- COVID-19 vaccination in children aged 5 to 11 years (PICKids)
Adverse Events of Special Interest
Summary
- Protective benefits of COVID-19 vaccination outweigh the potential risks
Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia (Data as of 31st December 2021)
Introduction
- How NPRA collects adverse event reports?
- How NPRA processes AEFI reports and monitors safety of COVID-19 vaccines?
Total Doses of COVID-19 Vaccines Administered
Rate of Reported Adverse Events
- AEFI responses received via MySejahtera application
- AEFI reports received via NPRA Reporting System
- COVID-19 vaccination in the age of 12 to 17 years
- Booster doses
Adverse Events of Special Interest
Summary
- Protective benefits of COVID-19 vaccination outweigh the potential risks
Summary Report on Adverse Events Following Immunisation of COVID-19 Vaccines in Malaysia (Data as of 29th October 2021)
Introduction
- How NPRA collects adverse event reports?
- How NPRA processes AEFI reports and monitors safety of COVID-19 vaccines?
Total Doses of COVID-19 Vaccines Administered
Rate of Reported Adverse Events
- AEFI responses received via MySejahtera application
- AEFI reports received via NPRA Reporting System
Summary
- Protective benefits of COVID-19 vaccination outweigh the potential risks
